PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company Reportsbluebird bio
bluebird bio(BLUE)
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SkysonaElivaldogene autotemcel2022-09-16
Adrenoleukodystrophy
ZyntegloBetibeglogene autotemcel2022-08-17
Beta-thalassemia
LyfgeniaLovotibeglogene autotemcel2023-12-08
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Betibeglogene autotemcel
beta-thalassemia
,
thalassemia
,
sickle cell anemia
Elivaldogene autotemcel
adrenoleukodystrophy
Lovotibeglogene autotemcel
sickle cell anemia
Bevifimod
adrenoleukodystrophy
Reproxalap
adrenoleukodystrophy
Hsct
adrenoleukodystrophy
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use